Target intelligence / Profile preview

Beta-1,3-N-acetylgalactosaminyltransferase 1 pseudogene 1 (B3GALNT1P1)

Target
B3GALNT1P1
Molecular classification
Pseudogene, Non-coding RNA (potentially, but evidence for RNA function specific to B3GALNT1P1 is lacking)
01

Overview

Beta-1,3-N-acetylgalactosaminyltransferase 1 pseudogene 1 is a processed pseudogene that is related to the parental gene beta-1,3-N-acetylgalactosaminyltransferase 1 (B3GALNT1). Like other pseudogenes, it is a DNA sequence that closely resembles the protein-coding gene but has acquired mutations or sequence changes that prevent it from producing a functional protein. In general, pseudogenes can sometimes play regulatory roles at the RNA level—such as acting as decoys for microRNAs or as modulators of parental gene expression—but no such function has specifically been attributed to B3GALNT1P1 to date. This gene is not a therapeutic, diagnostic, or prognostic target and has no direct involvement with drug action, disease mechanisms, or safety considerations. Its primary importance lies in the context of genome annotation and evolutionary genetics.

02

Mechanism of action

None applicable (not a protein; no drugs target it directly)

03

Biological functions

No established protein-coding or direct functional rolePossible regulatory or RNA-based roles by analogy to other pseudogenes, such as acting as a microRNA decoy or modulating parental gene expression (no specific published evidence for B3GALNT1P1)
04

Disease associations

None established for B3GALNT1P1 specificallyPseudogenes in general have been found to participate in cancer, diabetes, and other diseases through regulatory mechanisms, but no particular disease association is noted for B3GALNT1P1
05

Safety considerations

None (not used as a therapeutic target)
06

Biomarkers

None established for B3GALNT1P1 specifically (some pseudogene transcripts are being explored as biomarkers, but no evidence for this pseudogene)

Beyond the preview

Go deeper on Beta-1,3-N-acetylgalactosaminyltransferase 1 pseudogene 1 (B3GALNT1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,3-N-acetylgalactosaminyltransferase 1 pseudogene 1 (B3GALNT1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call